{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"hypertrophic-cardiomyopathy-and-renal-tubular-disease-due-to-mitochondrial-dna-mutation","columns":[{"gene":"","key":"population-6ca45a0091471057ad3f","label":"Hypertrophic cardiomyopathy with kidney anomalies due to mitochondrial DNA mutation","mondoId":"MONDO:0017933","onsetQualifier":null,"originColumnKey":"MONDO:0017933/ORPHA:324525","originalViews":[{"key":"MONDO:0017933/ORPHA:324525","label":"Hypertrophic cardiomyopathy with kidney anomalies due to mitochondrial DNA mutation","scopeLabel":"ORPHA:324525","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["0cc88d6f111d93801024a2639100be75d11ded217f9cf90e07b8c841fabe546c","0ceeaf422ff3f2ce3b82ce64d612b2a2d88268e9badcc301981e16c4a3385bd8","0ded2d4955725c6e64df77ec29b247730decc0ac2125c6263ee2e2171d08beb1","2f79374fdb4286895e15d403f5e5956f14b81f5276afb0713e9070f8ba463d8f","32149675de5d8d7900e7a0114fe88e6cfd44f432abf5ccaad33deed5003e3433","589c01704cc055eb272db679724837599473f29da02ff5086b9d98f4a69452fd","59d6eededd7989dbab056f37ceb550adb985b5375a470b53b0c8f216132d6083","5b022860341979f066deda48ad8adf29d5e9132e6e05d9605ea94d1916d17abf","7f82c482156b8d20f585ec7b955f277e12efd622942ad36ef1557a1234e2d459","825c262e86a1a2d253065a4fbc7d49b4d3fa9e0228833a7a5a7f0ebd3ec1b380","92d87d807d092f41e9661a52a4e92690feab1b62f8c77b1782caa9c5dcc9cea4","ab6dbb6f507aa3684b21307c84f79b5a76f05131c68032dfc2aed79d8510086f","b6fb2242b073d70bb9a768a432f451a284ae3d22fbc141a7555ed5e32f6ae2f9","b9c270e6d794c78a7f7a16f09e818b17931bc18f01a89d1797f30a9f30af73b4","bb4e0925cc2ae29d71fc2910c80ae5d6e44f74b3e27c8c0cfca3f9e45508e120","becae735a78d164eeacee9e355eabd44d43b3a7fff9f11bb03461899432f8b27","c6889573acddedaa3ec19d4d4ba0468ee0f2bb26c0fc6c1f86ce491eb0466565","c843b7843ef448085c867f30961d00f901bce7c0f7470b19c8a09148fff09cc8","d9a856b7b211f3f31d10d28dfd692f75191832bfc0c88f5d62cd6bd2614bb4bd","da78efe3ab96877053e3c380377999339c37585ad117538e5fb8d005abc79603"],"recordQualifiers":{},"scopeLabel":"ORPHA:324525","sourceIds":["ORPHA:324525"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-6ca45a0091471057ad3f"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0003535","HP:0001638","HP:0002059","HP:0012622","HP:0011923","HP:0011924","HP:0003236"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":20,"sourceGroups":{"orphanet":20}},"features":[{"hpoId":"HP:0003535","label":"3-Methylglutaconic aciduria","primary":true},{"hpoId":"HP:0001638","label":"Cardiomyopathy","primary":true},{"hpoId":"HP:0002059","label":"Cerebral atrophy","primary":true},{"hpoId":"HP:0012622","label":"Chronic kidney disease","primary":true},{"hpoId":"HP:0011923","label":"Decreased activity of mitochondrial complex I","primary":true},{"hpoId":"HP:0011924","label":"Decreased activity of mitochondrial complex III","primary":true},{"hpoId":"HP:0003236","label":"Elevated circulating creatine kinase activity","primary":true},{"hpoId":"HP:0001508","label":"Failure to thrive","primary":false},{"hpoId":"HP:0008872","label":"Feeding difficulties in infancy","primary":false},{"hpoId":"HP:0008947","label":"Floppy infant","primary":false},{"hpoId":"HP:0001263","label":"Global developmental delay","primary":false},{"hpoId":"HP:0003348","label":"Hyperalaninemia","primary":false},{"hpoId":"HP:0002521","label":"Hypsarrhythmia","primary":false},{"hpoId":"HP:0002151","label":"Increased circulating lactate concentration","primary":false},{"hpoId":"HP:0002490","label":"Increased CSF lactate","primary":false},{"hpoId":"HP:0001511","label":"Intrauterine growth retardation","primary":false},{"hpoId":"HP:0001947","label":"Renal tubular acidosis","primary":false},{"hpoId":"HP:0002093","label":"Respiratory insufficiency","primary":false},{"hpoId":"HP:0001250","label":"Seizure","primary":false},{"hpoId":"HP:0004322","label":"Short stature","primary":false}],"ledeHtml":"A mitochondrial oxidative phosphorylation disorder characterized by hypertrophic and dilated cardiomyopathy, failure to thrive, myopathy with generalized hypotonia and increased creatine kinase, developmental delay and/or regression with cerebral atrophy on brain MRI, renal manifestations including chronic renal failure, renal tubular acidosis and lactic acidosis. Additional clinical features include seizures and respiratory failure.","mondoId":"MONDO:0017933","node":{"canonicalSlug":"hypertrophic-cardiomyopathy-and-renal-tubular-disease-due-to-mitochondrial-dna-mutation","comparisons":[{"documentSha256":"97631818914229785fc45c89bb874735b5276e8563fb4127d0ab12756771f258","key":"legacy-hypertrophic-cardiomyopathy-and-renal-tubular-disease-due-to-mitochondrial-dna-mutation","kind":"legacy","label":"hypertrophic cardiomyopathy and renal tubular disease due to mitochondrial DNA mutation","memberIds":["MONDO:0017933"],"mondoId":"MONDO:0017933","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/hypertrophic-cardiomyopathy-and-renal-tubular-disease-due-to-mitochondrial-dna-mutation.97631818914229785fc45c89bb874735b5276e8563fb4127d0ab12756771f258.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Hypertrophic cardiomyopathy and renal tubular disease due to mitochondrial DNA mutation","originalSourceId":"ORPHA:324525","paragraphs":["A mitochondrial oxidative phosphorylation disorder characterized by hypertrophic and dilated cardiomyopathy, failure to thrive, myopathy with generalized hypotonia and increased creatine kinase, developmental delay and/or regression with cerebral atrophy on brain MRI, renal manifestations including chronic renal failure, renal tubular acidosis and lactic acidosis. Additional clinical features include seizures and respiratory failure."],"rawAttribution":"MONDO:0017933","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-21T17:03:42Z","upstream":"MONDO:0017933","url":"https://rarediseases.info.nih.gov/diseases/21442"},"ownColumnKeys":["population-6ca45a0091471057ad3f"],"publication":"published","relationships":[{"kind":"parent","label":"mitochondrial oxidative phosphorylation disorder","mondoId":"MONDO:0016387","slug":"mitochondrial-oxidative-phosphorylation-disorder"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"pending"},"records":[{"frequencyKind":"range","key":"0cc88d6f111d93801024a2639100be75d11ded217f9cf90e07b8c841fabe546c","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:324525","disease_name":"Hypertrophic cardiomyopathy with kidney anomalies due to mitochondrial DNA mutation","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0003348","is_excluded":false,"label":"Hyperalaninemia","onset_id":null,"reference":"ORPHA:324525","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"0ceeaf422ff3f2ce3b82ce64d612b2a2d88268e9badcc301981e16c4a3385bd8","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:324525","disease_name":"Hypertrophic cardiomyopathy with kidney anomalies due to mitochondrial DNA mutation","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002521","is_excluded":false,"label":"Hypsarrhythmia","onset_id":null,"reference":"ORPHA:324525","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"0ded2d4955725c6e64df77ec29b247730decc0ac2125c6263ee2e2171d08beb1","raw":{"aspect":"P","body_system":"growth","disease_id":"ORPHA:324525","disease_name":"Hypertrophic cardiomyopathy with kidney anomalies due to mitochondrial DNA mutation","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0004322","is_excluded":false,"label":"Short stature","onset_id":null,"reference":"ORPHA:324525","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"2f79374fdb4286895e15d403f5e5956f14b81f5276afb0713e9070f8ba463d8f","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:324525","disease_name":"Hypertrophic cardiomyopathy with kidney anomalies due to mitochondrial DNA mutation","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002151","is_excluded":false,"label":"Increased circulating lactate concentration","onset_id":null,"reference":"ORPHA:324525","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"32149675de5d8d7900e7a0114fe88e6cfd44f432abf5ccaad33deed5003e3433","raw":{"aspect":"P","body_system":"growth","disease_id":"ORPHA:324525","disease_name":"Hypertrophic cardiomyopathy with kidney anomalies due to mitochondrial DNA mutation","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001508","is_excluded":false,"label":"Failure to thrive","onset_id":null,"reference":"ORPHA:324525","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"589c01704cc055eb272db679724837599473f29da02ff5086b9d98f4a69452fd","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:324525","disease_name":"Hypertrophic cardiomyopathy with kidney anomalies due to mitochondrial DNA mutation","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0003236","is_excluded":false,"label":"Elevated circulating creatine kinase activity","onset_id":null,"reference":"ORPHA:324525","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"59d6eededd7989dbab056f37ceb550adb985b5375a470b53b0c8f216132d6083","raw":{"aspect":"P","body_system":"respiratory","disease_id":"ORPHA:324525","disease_name":"Hypertrophic cardiomyopathy with kidney anomalies due to mitochondrial DNA mutation","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002093","is_excluded":false,"label":"Respiratory insufficiency","onset_id":null,"reference":"ORPHA:324525","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"5b022860341979f066deda48ad8adf29d5e9132e6e05d9605ea94d1916d17abf","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:324525","disease_name":"Hypertrophic cardiomyopathy with kidney anomalies due to mitochondrial DNA mutation","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001638","is_excluded":false,"label":"Cardiomyopathy","onset_id":null,"reference":"ORPHA:324525","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"7f82c482156b8d20f585ec7b955f277e12efd622942ad36ef1557a1234e2d459","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:324525","disease_name":"Hypertrophic cardiomyopathy with kidney anomalies due to mitochondrial DNA mutation","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001250","is_excluded":false,"label":"Seizure","onset_id":null,"reference":"ORPHA:324525","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"825c262e86a1a2d253065a4fbc7d49b4d3fa9e0228833a7a5a7f0ebd3ec1b380","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:324525","disease_name":"Hypertrophic cardiomyopathy with kidney anomalies due to mitochondrial DNA mutation","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001947","is_excluded":false,"label":"Renal tubular acidosis","onset_id":null,"reference":"ORPHA:324525","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"92d87d807d092f41e9661a52a4e92690feab1b62f8c77b1782caa9c5dcc9cea4","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:324525","disease_name":"Hypertrophic cardiomyopathy with kidney anomalies due to mitochondrial DNA mutation","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0008872","is_excluded":false,"label":"Feeding difficulties in infancy","onset_id":null,"reference":"ORPHA:324525","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"ab6dbb6f507aa3684b21307c84f79b5a76f05131c68032dfc2aed79d8510086f","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:324525","disease_name":"Hypertrophic cardiomyopathy with kidney anomalies due to mitochondrial DNA mutation","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0008947","is_excluded":false,"label":"Floppy infant","onset_id":null,"reference":"ORPHA:324525","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"b6fb2242b073d70bb9a768a432f451a284ae3d22fbc141a7555ed5e32f6ae2f9","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:324525","disease_name":"Hypertrophic cardiomyopathy with kidney anomalies due to mitochondrial DNA mutation","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001263","is_excluded":false,"label":"Global developmental delay","onset_id":null,"reference":"ORPHA:324525","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"b9c270e6d794c78a7f7a16f09e818b17931bc18f01a89d1797f30a9f30af73b4","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:324525","disease_name":"Hypertrophic cardiomyopathy with kidney anomalies due to mitochondrial DNA mutation","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0012622","is_excluded":false,"label":"Chronic kidney disease","onset_id":null,"reference":"ORPHA:324525","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"bb4e0925cc2ae29d71fc2910c80ae5d6e44f74b3e27c8c0cfca3f9e45508e120","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:324525","disease_name":"Hypertrophic cardiomyopathy with kidney anomalies due to mitochondrial DNA mutation","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0011924","is_excluded":false,"label":"Decreased activity of mitochondrial complex III","onset_id":null,"reference":"ORPHA:324525","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"becae735a78d164eeacee9e355eabd44d43b3a7fff9f11bb03461899432f8b27","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:324525","disease_name":"Hypertrophic cardiomyopathy with kidney anomalies due to mitochondrial DNA mutation","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0003535","is_excluded":false,"label":"3-Methylglutaconic aciduria","onset_id":null,"reference":"ORPHA:324525","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"c6889573acddedaa3ec19d4d4ba0468ee0f2bb26c0fc6c1f86ce491eb0466565","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:324525","disease_name":"Hypertrophic cardiomyopathy with kidney anomalies due to mitochondrial DNA mutation","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002490","is_excluded":false,"label":"Increased CSF lactate","onset_id":null,"reference":"ORPHA:324525","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"c843b7843ef448085c867f30961d00f901bce7c0f7470b19c8a09148fff09cc8","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:324525","disease_name":"Hypertrophic cardiomyopathy with kidney anomalies due to mitochondrial DNA mutation","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0011923","is_excluded":false,"label":"Decreased activity of mitochondrial complex I","onset_id":null,"reference":"ORPHA:324525","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"d9a856b7b211f3f31d10d28dfd692f75191832bfc0c88f5d62cd6bd2614bb4bd","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:324525","disease_name":"Hypertrophic cardiomyopathy with kidney anomalies due to mitochondrial DNA mutation","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002059","is_excluded":false,"label":"Cerebral atrophy","onset_id":null,"reference":"ORPHA:324525","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"da78efe3ab96877053e3c380377999339c37585ad117538e5fb8d005abc79603","raw":{"aspect":"P","body_system":"growth","disease_id":"ORPHA:324525","disease_name":"Hypertrophic cardiomyopathy with kidney anomalies due to mitochondrial DNA mutation","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001511","is_excluded":false,"label":"Intrauterine growth retardation","onset_id":null,"reference":"ORPHA:324525","source_release":"2026-06-23"},"sourceGroups":["orphanet"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/21442\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0017933\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>MONDO:0017933</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>A mitochondrial oxidative phosphorylation disorder characterized by hypertrophic and dilated cardiomyopathy, failure to thrive, myopathy with generalized hypotonia and increased creatine kinase, developmental delay and/or regression with cerebral atrophy on brain MRI, renal manifestations including chronic renal failure, renal tubular acidosis and lactic acidosis. Additional clinical features include seizures and respiratory failure.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/21442\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"hypertrophic-cardiomyopathy-and-renal-tubular-disease-due-to-mitochondrial-dna-mutation","sourceDocuments":[{"name":"GARD: Hypertrophic cardiomyopathy and renal tubular disease due to mitochondrial DNA mutation","reviewed":null,"source_release":"2026-10-21T17:03:42Z","url":"https://rarediseases.info.nih.gov/diseases/21442"},{"name":"MONDO: hypertrophic cardiomyopathy and renal tubular disease due to mitochondrial DNA mutation","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0017933"}],"sourceNote":"","synonyms":["hypertrophic cardiomyopathy and renal tubular disease due to mtDNA mutation"],"takeawayHtml":"","title":"hypertrophic cardiomyopathy and renal tubular disease due to mitochondrial DNA mutation"},"schemaVersion":1}
